Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Wireless Monitoring Informs Acid Reflux Therapy
Clinical Breakthroughs

Wireless Monitoring Informs Acid Reflux Therapy

By Will DossOct 22, 2020
Share
Facebook Twitter Email
John Pandolfino, MD, ’94 ’96 ’01 GME, the Hans Popper Professor and chief of Gastroenterology and Hepatology in the Department of Medicine, was senior author of the study published in Gastroenterology.

Measuring acid reflux with a wireless electrode can help clinicians determine if patients are ready to stop taking proton pump inhibitors, a medication commonly prescribed for acid reflux disease.

These findings, published in the journal Gastroenterology, provide a framework for determining if a patient requires the life-long medication, according to John Pandolfino, MD, ’94 ’96 ’01 GME, the Hans Popper Professor, chief of Gastroenterology and Hepatology in the Department of Medicine and senior author of the study.

“This provides a strong assessment of their underlying acid exposure, and based on that data, you can make an educated and personalized decision for the patient,” Pandolfino said.

Proton pump inhibitor (PPI) therapy reduces stomach acid production and is a standard and effective treatment for stomach-acid related disorders, including gastroesophageal reflux disease (GERD). However, acid-reflux is just one of many possible conditions that could cause heartburn-like symptoms, and simply discontinuing the medication to see if symptoms return is not an effective test of whether or not the medication is medically useful, according to Pandolfino.

“Even if symptoms come back, you may still not have reflux because there’s a strong placebo response,” Pandolfino said. “On the other hand, there are patients who for many reasons don’t want to take medicine every day, who really need this medication and could come in with serious complications if they stop.”

In the study, Pandolfino and his collaborators used a “Bravo™ test,” a wireless device implanted in the esophagus that measures acidity. Over the course of three years, a pool of 100 participants underwent wireless monitoring during rolling three-week periods in which they stopped taking PPIs.

If their symptoms subsided and acid exposure was minor or nonexistent, patients were able to stop taking PPIs permanently — an outcome achieved by 34 participants.

Among those participants, the strongest predictor of being able to discontinue PPI therapy was the number of days with low or no acid exposure. Participants with zero days of acid exposure above a low threshold had 10 times the odds of discontinuing PPI therapy compared to participants with four days of acid exposure above the threshold.

These findings point to days without acid exposure, measured using the Bravo™ test, as a clinically relevant measure for whether or not a patient can discontinue PPI therapy, according to Pandolfino.

“This allows you to utilize a personalized approach and clinically phenotype patients and better dictate their therapy,” Pandolfino said. “Someone who doesn’t need to be on a PPI is wasting a lot of money and subjecting themselves to some potential mild side-effects.”

In addition, the Bravo™ test can also serve as a confirmation that some patients do need PPI therapy, lest they risk serious complications.

“Some people, even though they are suffering with their symptoms, just don’t want to take this medication,” Pandolfino said. “This gives you the ability to say, if you don’t take this you could have serious complications and this gives you confidence that the risk benefit is in favor of benefit with therapy.”

Leila Kia, MD, ’12 ’16 GME, and Dustin Carlson, MD, ’12 ’16 GME, both assistant professors of Medicine in the Division of Gastroenterology and Hepatology, were co-authors of the study.

This study was funded by National Institutes of Health grant R01 DK092217-04.

Health and Lifestyle Patient Care Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.